ipernica secures rights to valuable IP from leading research groups and generates revenue by licensing the technologies to international corporations.

For the vast majority of IP created within research laboratories, the most sensible commercialisation path is licensing to a global leader in the relevant industry.

ipernica has the skills, networks and experience to identify potential licensees of new technologies and deliver profitable licensing programs.

The majority of IP resulting from R&D is not appropriate for spinning out into a new company as spin-outs require significant funding.  On the other hand, licences usually require far less capital.  With the right application, licences can produce significant ongoing royalties.

In the area of Innovation Licensing, ipernica has:

• a credible pedigree of successful IP out-licensing;
• strong relationships with significant research institutes (CSIRO, DSTO, NICTA, Universities and CRCs) and companies;
• a network of international consultants and industry specialists; and
• the personnel and skills across both life and physical sciences.